Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

In Vitro Diagnostics Market Outlook

The in vitro diagnostics market is set to thrive at a steady CAGR of 4.8% during the forecast period. The market holds a share of US$ 81.3billion in 2023 while it is anticipated to cross a value of US$ 129.9billion by 2033.

The research report on in vitro diagnostics market explains that growing awareness amongst people regarding their health checkups is experiencing a surge. Thus, the demand for advanced in vitro diagnostics is rising as it is one of the latest methods of detecting issues. From testing the blood, and urine samples to diagnosing them in the lab and monitoring them most skillfully is the key to any diagnostic operations. Furthermore, the addition of advanced automation and instruments along with quality controls and quality assurance software is likely to transform the market in the future. The government increasing its spending on microfluidic technology to enhance in vitro diagnostic solutions. The integration of biotechnology, laboratories, and diagnostic technology is likely to strengthen and save the future of in vitro diagnostics market.

The in vitro diagnostics market outlook states that well-established technologies like lateral flow strips and immunosensors, as well as the continued downsizing of circuits and improved computational capacity of devices, fueled this growth of in-vitro diagnostic medical devices. This shift from a centralized to the point care testing system is expected to drive the demand for in-vitro diagnostics forward. Furthermore, the rising cases of chronic diseases force people to keep a check on their health and change their lifestyle according to it.

Attributes Details
In Vitro Diagnostics Market CAGR (2023 to 2033) 4.8%
In Vitro Diagnostics Market Size (2023) US$ 81.3 billion
In Vitro Diagnostics Market Size (2033) US$ 129.9 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How is the Future Outlook (2023 to 2033)  for In Vitro Diagnostics Market in Comparison to the Historical Pattern (2017 to 2022)? 

From 2017 to 2022, the global in vitro diagnostics market registered a comparatively higher CAGR of 5.9%. The rising frequency of chronic and infectious diseases is responsible for the rise in the usage of in-vitro diagnostics medical devices. The rising prevalence of chronic diseases drives the need for extensive diagnostic procedures, which drives the market.

The current in-vitro diagnostics market outlook is positively rising as a result of the IVD market's utilization of modern technology. A paradigm change has occurred, with traditional diagnostics giving way to a new wave of diagnostics that act at the gene level.

The incorporation of modern technologies in the IVD platform, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS), makes this possible. In addition, the sales of in-vitro diagnostics are likely to be driven by an increase in product introductions with enhanced features The In vitro diagnostics market is anticipated to thrive at a CAGR of 4.8% between 2023 and 2033.

What are the Primary In Vitro Diagnostics Market Dynamics?

The frequency of age-related ailments is predicted to rise dramatically as the world's elderly population grows rapidly.

Biomarkers also have a lot of clinical value and interest in the medical business because they can help with illness screening, treatment, and medication.

The accessibility of biomolecular tools and the incorporation of biomarkers are projected to aid in the creation of a new variety of condition-specific tests, giving rise to new in vitro diagnostics products.

The IVD industry is characterized by fierce competition. As competitors seek to maintain their presence and drive R&D and innovation, the in vitro diagnostics market adoption is fast evolving with automation, AI, and advanced data analytics.

To fulfill the changing demand for in vitro diagnostics from providers such as clinical laboratories and point-of-care diagnostic centers, companies have begun to automate diagnostic testing.

With the introduction of quick Proof of Concept technology, facilities were able to streamline workflows and reduce personnel requirements to process a larger sample load.

Diagnostic testing and laboratory industries have banded together to aid public health efforts, provide data for testing, and develop new transformational diagnostic technologies.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining the In Vitro Diagnostics Market?

Due to continual technological advancements in medicine, countries with unfavorable reimbursement scenarios have issues in their financial systems.

A few years ago, Medicare in the United States amended its funding method for various in-vitro diagnostic tests, including molecular diagnostic testing.

Some molecular pathology tests don't have their own Healthcare Common Procedure Coding System (HCPCS) codes; thus, they're invoiced with unlisted codes instead. Medicare Administrative Contractors (MACs) set a payment amount for their local jurisdictions in such circumstances.

Molecular diagnostic tests focused on NGS analysis panels and cancer detection tests are among the diagnostics available. These changes in the reimbursement system are projected to harm the molecular and genetic testing market in the United States, stifling the in-vitro diagnostics market growth.

What are the Key Threats Prevalent in the In Vitro Diagnostics Market?

Clinical laboratories in key markets are still evolving; technicians confront operational issues in assuring effective sample procurement, storage, and transportation, especially as new technologies like NGS and lab-on-a-chip PCR machines become more widely adopted.

To reduce cross-contamination and ensure efficient time management, laboratory space must also be modified to fulfill the requirements of conducting certain diagnostic procedures needed for pathogen detection. This drives up the expense of maintaining and operating modern in-vitro diagnostic test kits and instruments, especially those that can only handle a single sample type.

Furthermore, clinical laboratories must implement innovative technology capable of rapid sample diagnosis due to the quick mutation of microorganisms and the increased incidence of epidemics. The lack of competent laboratory professionals to operate modern diagnostic equipment, particularly in emerging areas, has hampered their broad acceptance.

Another barrier faced by in-vitro diagnostics companies is a reluctance to move away from manual procedures and toward automation. Many providers find it difficult or impossible to make a move from manual or traditional procedures to IT-based approaches.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

What are the Opportunities Available to the Market Players in the In Vitro Diagnostics Market?

The integration of biomarkers and the availability of biomolecular tools are likely to aid in the development of a new set of condition-specific tests, thereby expanding the in vitro diagnostics industry reach.

The development of new biomarkers for diagnosing various diseases, particularly cancer, has revolutionized medicine. Biomarkers have become more effective in illness identification thanks to advances in sequencing technology and a better understanding of genetics.

As a result, demand for precision medicine is likely to rise, providing considerable potential prospects for in-vitro diagnostics market size growth.

Comparative View of In Vitro Diagnostics Market

In Vitro Diagnostics Market:

Attributes In Vitro Diagnostics Market
CAGR (2023 to 2033) 4.8%
Market Value (2033) US$ 129.9 billion
Growth Factor Growing prevalence of chronic diseases due to changes in lifestyles and the rise in the geriatric population
Opportunity A significant shift from a centralized to point of care testing system
Key Trends A rise in the adoption of fully automated instruments is driving the market forward.

Molecular Diagnostics Market:

Attributes Molecular Diagnostics Market
CAGR (2023 to 2033) 11.8%
Market Value (2033) US$ 69.86 billion
Growth Factor Rising investment in research and development initiatives.
Opportunity The market for companion diagnostics has a lot of room to develop as interest in high-priced specialist treatments and better medications grows
Key Trends The rising incidences of Infectious diseases and cancer globally.

Microfluidics Market:

Attributes In Vitro Diagnostics Market
CAGR (2023 to 2033) 4.8%
Market Value (2033) US$ 129.9 billion
Growth Factor Growing prevalence of chronic diseases due to changes in lifestyles and the rise in the geriatric population
Opportunity A significant shift from a centralized to point of care testing system
Key Trends A rise in the adoption of fully automated instruments is driving the market forward.

Country-wise Insights

Region Absolute Market Growth
United States US$ 18.1 billion
United Kingdom US$ 1.2 billion
China US$ 6.2 billion
Japan US$ 2.1 billion
India US$ 3.2 billion

Which Region leads the Market in terms of Market Share?

Increased Healthcare Spending along with the Rising Prevalence of Chronic Diseases like Diabetes and Cancer are propelling the Regional Growth

Region Attributes
United States Market CAGR (2023 to 2033) 4.4%
United States Market Absolute Doller Growth (US$ million/billion) US$ 18.1 billion

United States is expected to be the leading regional market for in vitro diagnostics during the forecast period, owing to its well-connected healthcare system and increased healthcare awareness among patients, as well as Obama's Affordable Care Act (ACA), technological advancements, and a recovering American economy. The United States regional market is likely to surge at a CAGR of 4.4% between 2023 and 2033 while it is anticipated to reach a value of US$ 51.9 billion by 2033.

Other factors that contribute to the market's growth include the widespread availability of devices, increased knowledge about their usage, and the existence of a significant number of senior populations suffering from a variety of chronic ailments.

What makes India a Leading In Vitro Diagnostics Market in terms of CAGR?

Region Attributes
Indian Market CAGR (2023 to 2033) 8.8%
Indian Market Absolute Doller Growth (US$ million/billion) US$ 3.2 billion

India with its leap in the vaccine race is expanding its roots in the diagnostics industry and is flourishing at a leading CAGR of 8.8% between 2023 and 2033. The regional market is anticipated to reach a value of US$ 5.7 billion by 2033. The growth is attributed to the increase in healthcare expenditure and the incidence of diabetes in the region, India is predicted to expand at the quickest rate throughout the projection period.

Various reasons, such as the large patient population of other chronic illnesses that necessitate IVD testing, also contribute to the overall Indian market's growth.

Category-wise Insights

Segment Top Technology
Top Sub-segment Clinical Chemistry
CAGR (2017 to 2022) 5.4%
CAGR (2023 to 2033) 4.2%
Segment Top Application
Top Sub-segment Infectious Disease
CAGR (2017 to 2022) 6.0%
CAGR (2023 to 2033) 4.6%

Wider Panel Options along with the Specialty Chemical Tests are Propelling the Segment’s Growth

The technology category is divided into molecular diagnostics, immunoassays, clinical chemistry, point of care, etc. Clinical chemistry holds a substantial market share as it covers most of the diagnostic panels. The segment thrives at a higher leading CAGR of 4.2% between 2023 and 2033.

Higher Consumption along with Increased Penetration is the driving factors for the Segment’s Growth

The application segment is likely to be driven by an increase in market participants developing infectious disease detection tests for in vitro diagnostics. The infectious disease led the market in 2020, accounting for 41.8 percent of total revenue, owing to the rising prevalence of infectious diseases such as SARS-CoV-2, HIV, AIDS, TB, and pneumonia. The segment now thrives at a CAGR of 4.2% between 2023 and 2033.

For example, Siemens Healthineers' 12 novel tests for viral hepatitis and other disorders obtained premarket approval from the United States Food and Drug Administration in December 2018. These tests are utilized in the Atellica Solution, which offers hepatitis C screening, diagnosis, and monitoring.

Competition Scenario

The market for in vitro diagnostics is indeed competitive, with numerous significant competitors. The industry is currently dominated by a few big companies in terms of market share. Mid-size to smaller businesses, on the other hand, are expanding their market presence by releasing new items at reduced prices, thanks to technical improvements and product innovations. In addition, important players are active in strategic alliances with firms that complement their product lines, such as acquisitions, collaborations, and partnerships.

Market Developments

  • F. Hoffmann-La Roche Ltd. and GenMark Diagnostics, Inc. announced their formal merger agreement in March 2021. Roche may benefit from this purchase by gaining access to GenMark's innovative technology for testing a wide spectrum of infections with a single patient sample.
  • Becton Dickinson and Company completed the acquisition of NAT Diagnostics in May 2020 to broaden its infectious disease point-of-care testing portfolio.
  • Siemens Healthineers AG, BD (Becton, Dickinson, and Company), Seegene Inc., DiaSorin S.p.A., and Quest Diagnostics Incorporated are among the other industry participants having a substantial presence in the worldwide market. To grow their market share, these businesses are anticipated to focus on launching new items.

Key Contributors

  • Thermo Fischer Scientific Inc
  • Abbott Laboratories
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche AG

Key Segments

By Product & Service:

  • Reagents
  • Instruments
  • Services & Software

By Technology:

  • Immunodiagnostics
  • Hematology
  • Molecular diagnostics
  • Tissue diagnostics
  • Clinical chemistry
  • Others

By Application:

  • Infectious diseases
  • Cancer
  • Cardiac diseases
  • Immune system disorders
  • Nephrological diseases
  • Gastrointestinal diseases
  • Others

By End User:

  • Standalone laboratories
  • Hospitals
  • Academics & Medical Schools
  • Point-of-Care
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the In Vitro Diagnostics Market Currently?

In 2023, the market size is estimated to be US$ 81.3 billion.

Who are the Key In Vitro Diagnostics Market Players?

Thermo Fischer Scientific Inc., Abbott Laboratories, and Siemens Healthcare GmbH are the key players in the market.

What Opportunities Await for the Market Players?

Rise in demand for precision medicine is likely to be opportunistic for market players.

What are Key Challenges in the In Vitro Diagnostics Market?

Need for more competent laboratory professionals is the key challenge.

Which Region Holds High Lucrativeness?

North America is expected to be the leading region.

What is the Growth Forecast for the In Vitro Diagnostics Market?

The market is expected to register a CAGR of 4.8% through 2033.

Table of Content

1. Executive Summary | In Vitro Diagnostics Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        5.3.1. Molecular Diagnostics

            5.3.1.1. Polymerase Chain Reaction

            5.3.1.2. Isothermal Nucleic Acid

            5.3.1.3. Microarray

            5.3.1.4. Hybridization

            5.3.1.5. DNA Sequencing & Next Generation Sequencing

            5.3.1.6. Other MDx Technologies

        5.3.2. Immunoassays

            5.3.2.1. ELISA

            5.3.2.2. RIA

            5.3.2.3. ELISpot Assay

            5.3.2.4. Rapid Test

            5.3.2.5. Other Immunoassay techniques

        5.3.3. Clinical Chemistry

            5.3.3.1. Basic Metabolite

            5.3.3.2. Electrolyte Panel

            5.3.3.3. Liver Panel

            5.3.3.4. Lipid Panel

            5.3.3.5. Renal Panel

        5.3.4. Point of Care

        5.3.5. Whole Blood Glucose Monitoring

        5.3.6. Hematology

        5.3.7. Clinical Microbiology

        5.3.8. Coagulation and Hemostasis

        5.3.9. Others

    5.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Drug Testing

        6.3.2. Infectious Disease

        6.3.3. Oncology

        6.3.4. Metabolic Disease

        6.3.5. Autoimmune Disease

        6.3.6. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End-user 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-user , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user , 2023 to 2033

        7.3.1. Diagnostics Laboratories

        7.3.2. Hospitals

        7.3.3. Academic & Research Centers

        7.3.4. Home Care

        7.3.5. Others

    7.4. Y-o-Y Growth Trend Analysis By End-user , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End-user , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Technology

        9.2.3. By Application

        9.2.4. By End-user

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Technology

        9.3.3. By Application

        9.3.4. By End-user

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Technology

        10.2.3. By Application

        10.2.4. By End-user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Technology

        10.3.3. By Application

        10.3.4. By End-user

    10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. United Kingdom

            11.2.1.2. Spain

            11.2.1.3. Germany

            11.2.1.4. Italy

            11.2.1.5. France

            11.2.1.6. Rest of Europe

        11.2.2. By Technology

        11.2.3. By Application

        11.2.4. By End-user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Technology

        11.3.3. By Application

        11.3.4. By End-user

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. China

            12.2.1.3. Japan

            12.2.1.4. Australia & New Zealand

            12.2.1.5. Rest of Asia Pacific

        12.2.2. By Technology

        12.2.3. By Application

        12.2.4. By End-user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Technology

        12.3.3. By Application

        12.3.4. By End-user

    12.4. Key Takeaways

13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. South Africa

            13.2.1.2. GCC Countries

            13.2.1.3. Rest of Middle East and Africa

        13.2.2. By Technology

        13.2.3. By Application

        13.2.4. By End-user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Technology

        13.3.3. By Application

        13.3.4. By End-user

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. USA

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By Technology

            14.1.2.2. By Application

            14.1.2.3. By End-user

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By Technology

            14.2.2.2. By Application

            14.2.2.3. By End-user

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By Technology

            14.3.2.2. By Application

            14.3.2.3. By End-user

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By Technology

            14.4.2.2. By Application

            14.4.2.3. By End-user

    14.5. United Kingdom

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By Technology

            14.5.2.2. By Application

            14.5.2.3. By End-user

    14.6. Spain

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By Technology

            14.6.2.2. By Application

            14.6.2.3. By End-user

    14.7. Germany

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By Technology

            14.7.2.2. By Application

            14.7.2.3. By End-user

    14.8. Italy

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By Technology

            14.8.2.2. By Application

            14.8.2.3. By End-user

    14.9. France

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By Technology

            14.9.2.2. By Application

            14.9.2.3. By End-user

    14.10. India

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By Technology

            14.10.2.2. By Application

            14.10.2.3. By End-user

    14.11. China

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By Technology

            14.11.2.2. By Application

            14.11.2.3. By End-user

    14.12. Japan

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By Technology

            14.12.2.2. By Application

            14.12.2.3. By End-user

    14.13. Australia & New Zealand

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By Technology

            14.13.2.2. By Application

            14.13.2.3. By End-user

    14.14. South Africa

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By Technology

            14.14.2.2. By Application

            14.14.2.3. By End-user

    14.15. GCC Countries

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By Technology

            14.15.2.2. By Application

            14.15.2.3. By End-user

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Technology

        15.3.3. By Application

        15.3.4. By End-user

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Roche Diagnostics

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Siemens Healthineers

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Danaher Corporation

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Abbott

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Thermo Fisher Scientific

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Johnson & Johnson

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Becton, Dickinson and Company

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Bio-Rad Laboratories

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Sysmex Corporation

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. bioMérieux

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

        16.1.11. DiaSorin

            16.1.11.1. Overview

            16.1.11.2. Product Portfolio

            16.1.11.3. Profitability by Market Segments

            16.1.11.4. Sales Footprint

            16.1.11.5. Strategy Overview

                16.1.11.5.1. Marketing Strategy

        16.1.12. Ortho Clinical Diagnostics

            16.1.12.1. Overview

            16.1.12.2. Product Portfolio

            16.1.12.3. Profitability by Market Segments

            16.1.12.4. Sales Footprint

            16.1.12.5. Strategy Overview

                16.1.12.5.1. Marketing Strategy

        16.1.13. QIAGEN N.V.

            16.1.13.1. Overview

            16.1.13.2. Product Portfolio

            16.1.13.3. Profitability by Market Segments

            16.1.13.4. Sales Footprint

            16.1.13.5. Strategy Overview

                16.1.13.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Application, 2017 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End-user , 2017 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Application, 2017 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End-user , 2017 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2017 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End-user , 2017 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Application, 2017 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End-user , 2017 to 2033

Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 18: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 19: Asia Pacific Market Value (US$ Million) Forecast by Application, 2017 to 2033

Table 20: Asia Pacific Market Value (US$ Million) Forecast by End-user , 2017 to 2033

Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2017 to 2033

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End-user , 2017 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Technology, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End-user , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Application, 2017 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End-user , 2017 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End-user , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-user , 2023 to 2033

Figure 17: Global Market Attractiveness by Technology, 2023 to 2033

Figure 18: Global Market Attractiveness by Application, 2023 to 2033

Figure 19: Global Market Attractiveness by End-user , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Technology, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End-user , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Application, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End-user , 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End-user , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-user , 2023 to 2033

Figure 37: North America Market Attractiveness by Technology, 2023 to 2033

Figure 38: North America Market Attractiveness by Application, 2023 to 2033

Figure 39: North America Market Attractiveness by End-user , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Technology, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End-user , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2017 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End-user , 2017 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-user , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-user , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Technology, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End-user , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Technology, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Application, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End-user , 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Application, 2017 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End-user , 2017 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End-user , 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-user , 2023 to 2033

Figure 77: Europe Market Attractiveness by Technology, 2023 to 2033

Figure 78: Europe Market Attractiveness by Application, 2023 to 2033

Figure 79: Europe Market Attractiveness by End-user , 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Asia Pacific Market Value (US$ Million) by Technology, 2023 to 2033

Figure 82: Asia Pacific Market Value (US$ Million) by Application, 2023 to 2033

Figure 83: Asia Pacific Market Value (US$ Million) by End-user , 2023 to 2033

Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Application, 2017 to 2033

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End-user , 2017 to 2033

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End-user , 2023 to 2033

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End-user , 2023 to 2033

Figure 97: Asia Pacific Market Attractiveness by Technology, 2023 to 2033

Figure 98: Asia Pacific Market Attractiveness by Application, 2023 to 2033

Figure 99: Asia Pacific Market Attractiveness by End-user , 2023 to 2033

Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 101: Middle East and Africa Market Value (US$ Million) by Technology, 2023 to 2033

Figure 102: Middle East and Africa Market Value (US$ Million) by Application, 2023 to 2033

Figure 103: Middle East and Africa Market Value (US$ Million) by End-user , 2023 to 2033

Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2017 to 2033

Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by End-user , 2017 to 2033

Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by End-user , 2023 to 2033

Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-user , 2023 to 2033

Figure 117: Middle East and Africa Market Attractiveness by Technology, 2023 to 2033

Figure 118: Middle East and Africa Market Attractiveness by Application, 2023 to 2033

Figure 119: Middle East and Africa Market Attractiveness by End-user , 2023 to 2033

Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Infectious Disease Diagnostics Market

Published : November 2022

Healthcare

In Vitro Fertilization Market

Published : June 2022

Explore Healthcare Insights

View Reports

In Vitro Diagnostics Market